OSI Systems has shed a quarter of its value in a month — and short sellers are refusing to blink.
The stock closed Tuesday at $212.01, down 4% on the week and 25% below where it traded in early May. That collapse traces directly to the May 4 earnings print, when OSIS fell nearly 17% in a single session and extended the loss to 18% over the following five days. It was the sharpest post-earnings move in the recent record. Short interest was already elevated heading into that report, and the crowd has added since — short interest as a percentage of free float now runs at 13.6%, up from around 12.5% at the start of May. The interesting tension here is that the stock has fallen dramatically, but the bears haven't covered. They've built.
Positioning reflects a market that is structurally sceptical but not in a panic-borrow situation. Short interest peaked near 14.4% of free float in mid-May, just after the earnings collapse, and has edged back to 13.6% — still elevated, still climbing relative to late April levels. The ORTEX short score sits at 67.7, consistent with the top third of the most-shorted universe, though it has drifted slightly lower over the past week from a 69 reading. Borrow is cheap at 0.57% annualised, and availability is comfortable at 185% — meaning roughly $1.85 worth of shares sits available to borrow for every $1 already borrowed. The lending market is in no way stressed. Options are similarly calm: the put/call ratio has dropped sharply to 0.59, well below its 20-day average of 0.90. That PCR normalisation is striking given the stock's weakness. In late April, the ratio spiked above 6 as investors scrambled for downside protection before earnings; that hedging pressure has now fully unwound. The current reading suggests the market is no longer bracing for another leg down — or at least, fewer traders are paying for that protection.
The Street remains constructively positioned but trimming its ambitions. Citigroup's John Godyn — who only initiated coverage in April with a $345 target — cut that target to $279 on May 18 while keeping his Buy rating. That's the most recent notable action, and it reads as a reality check rather than a capitulation: a bellwether firm lowers expectations post-disappointment without abandoning the bull case. JP Morgan holds at Neutral with a $262 target, providing the cautious anchor in the mix. The consensus mean target is $300, implying about 42% upside from here — a significant gap that reflects how badly the May earnings miss repriced the stock relative to analyst models. Factor scores are mixed. EV/EBIT ranks in the 71st percentile, suggesting reasonable value on an earnings basis, while EPS momentum over the past 30 and 90 days ranks in the 26th and 28th percentiles respectively — a sign that forward estimate revisions have been moving against the stock. The bull case rests on government contract momentum and international security demand; the bear case centres on government funding dependency, acquisition integration risk, and what the May earnings miss actually signals about the durability of recent growth.
Founder and Executive Chairman Deepak Chopra sold 20,000 shares on May 4 — the same day as the earnings collapse — at $281.84 per share, a $5.6m disposal. It was his second 20,000-share sale in three months, following a similar trade in February. These sales predate and coincide with the stock's sharp decline. Taken together, the net insider position over the past 90 days is a seller of around 20,065 shares worth roughly $5.7m. The pattern of repeat, round-lot founder sales at each price level lends a systematic feel — likely a pre-arranged plan — but the direction is uniformly one way.
Correlated peers traded in divergent directions this week. FN jumped 12.7% on the day. AEIS added 6%. APH gained 6.3% on the week. OSIS fell 4%. The underperformance is notable against a cohort that broadly caught a bid.
The next scheduled earnings date is August 21. What to watch between now and then: whether the PCR stays muted as the stock stabilises near $212, whether short interest begins to unwind as the post-earnings trade matures, and whether any of the remaining bulls on the Street revise their targets downward to close the wide gap between the $300 consensus and current reality.
See the live data behind this article on ORTEX.
Open OSIS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
